Gilead agrees to buy YM BioSciences for $510 million
13 December 2012
YM BioSciences - to partner or not to partner?
13 November 2012
Bargaining power boost for YM BioSciences
5 March 2012
Showing 1-6 of 6 articles
- 1
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
